A unique collection of 1436 FDA approved drugs for high throughput screening (HTS) and high content screening (HCS);Bioactivity and safety confirmed by pre-clinical research evidence and clinical trials;An effective tool for discovering new with old drugs and new drug target identification;Covers various research areas: oncology, cardiology, anti-inflammatory, immunology, neuropsychiatry, analgesia etcStructurally diverse, medicinally active, and cell permeable;Rich documentation with structure, target, IC50 value and biological activity description;NMR and HPLC/LCMS validated to ensure high purity.